Delivery Order SPE2DE22D0008-SPE2D625F22W7

This federal contract award SPE2DE22D0008|SPE2D625F22W7 was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization specializing in in vitro diagnostics, blood bank reagents, and quality control materials. The $5,160.00 firm fixed-price delivery order contract is for the provision of ALBACYTE antibody identification panels, a critical product supporting blood banking operations across federal healthcare systems.

Alba Bioscience, a subsidiary of Quotient Biodiagnostics, Inc., holds two significant Blanket Purchase Agreements (BPAs) with the Department of Veterans Affairs (VA) under the GSA Schedule 65-VII for in vitro diagnostics, reagents, and tests. The first BPA, awarded to Veterans Integrated Service Network 10, has a ceiling value of $109,420.35 and runs through September 30, 2029, focusing on red blood cell reagents. The second BPA, awarded to Veterans Integrated Service Network 1, has a potential value of $30,000 and extends through September 2028, targeting blood bank reagents. These contracts demonstrate Alba Bioscience's established position as a trusted supplier of essential medical products to federal healthcare systems. The current delivery order contract does not have a set-aside designation, reflecting the specialized nature of the company's medical offerings.